Meta-analysis compares extended-interval and standard dosing of natalizumab, highlighting dosing effects in multiple sclerosis.
This meta-analysis and systematic review will compare EID and SID in major clinical and radiological outcomes, with particular emphasis placed on the effects of various dosing intervals.
No takes yet. Share an insight, caveat, or question.
Hammadeh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: